Hamlet Pharma-BC Kick-off meeting
The kick-off meeting for a recently funded European Union Horizon 2020 project titled ‘HAMLET-BC: A Unique Bladder Cancer Therapeutic, Acting with Great Precision’ was recently held with great success.This 2-year project falls under the H2020 EIC Accelerator Program to fund projects of for-profit SMEs that have ground-breaking concepts that could shape new markets or disrupt existing ones in Europe and worldwide. The goal of HAMLET-BC project is to accelate development of Alpha1H as novel treatment for bladder cancer. Hamlet Pharma provides new cancer treatments based on a peptide-based